Hematological Malignancies Initiative Launch: Mini-Symposium
Join us for the official launch of the Hematological Malignancies Initiative at the Herbert Irving Comprehensive Cancer Center.
This mini-symposium will bring together investigators and clinicians from across Columbia to introduce the initiative, share highlights of ongoing research in hematologic malignancies, and outline opportunities for collaboration, education, and future programming.
The event will feature an overview of the initiative’s goals and structure, research presentations spanning discovery through clinical application, and time for discussion and connection across disciplines.
All faculty, trainees, and staff with an interest in hematologic malignancies are encouraged to attend.
AGENDA:
Welcome and Opening Remarks
Katrina Armstrong, MD
Scientific Presentations:
Hematological Malignancies Initiative: Vision and Overview
Stavroula Kousteni, PhD
AI and Computational Biology in the Understanding and Treatment of Hematologic Malignancies
Raul Rabadan, PhD
CAR-T Immunotherapy: Clinical Perspectives
Ran Reshef, MD
Cytotoxic CD4+T Cell-Based Immunotherapy
Pawel Muranski, MD, PhD
Panel Discussion: Integrating Basic, Translational, and Clinical Programs in Hematologic Malignancies
Panelists: Jennifer Amengual, MD; Sergei Doulatov, PhD; Michael Hughes, MD; Nicole Lamanna, MD; Suzanne Lentzsch, MD; Teresa Palomera, PhD; Laura Pasqualucci, PhD; Azra Raza, MD; Lewis Silverman, MD; Aaron Viny, MD, MS; Lili Wang, MD
Concluding Remarks
Anil Rustgi, MD
Marilyn Skony Stamm
Joe Walker
Reception immediately following